Ben Anderson Flatt Sr. - 04 Mar 2026 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
Senior VP & CIO
Signature
/s/ Ben Anderson Flatt
Issuer symbol
NHC
Transactions as of
04 Mar 2026
Net transactions value
$0
Form type
4
Filing time
06 Mar 2026, 16:27:36 UTC
Previous filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
FLATT BEN ANDERSON SR Senior VP & CIO 100 VINE STREET, MURFREESBORO /s/ Ben Anderson Flatt 06 Mar 2026 0001699471

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Common Stock Options Exercise +3,733 +24% $53.94* 19,192 04 Mar 2026 Direct F1
transaction NHC Common Stock Options Exercise +4,000 +21% $94.10* 23,192 04 Mar 2026 Direct F2
transaction NHC Common Stock Options Exercise +4,500 +19% $90.62* 27,692 04 Mar 2026 Direct F3
transaction NHC Common Stock Tax liability -8,142 -29% $172.83* 19,550 04 Mar 2026 Direct F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Options Exercise -3,733 -50% $0.000000* 3,734 04 Mar 2026 Common Stock 7,467 $53.94 Direct F1
transaction NHC Option to Purchase Common Stock Options Exercise -4,000 -33% $0.000000* 8,000 04 Mar 2026 Common Stock 12,000 $94.10 Direct F2
transaction NHC Option to Purchase Common Stock Options Exercise -4,500 -33% $0.000000* 9,000 04 Mar 2026 Common Stock 13,500 $90.62 Direct F3
holding NHC Option to Purchase Common Stock 14,000 04 Mar 2026 Common Stock 14,000 $157.13 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F3 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F4 Shares were withheld by the Company to pay the exercise price and withholding tax obligations.
F5 Total amount of shares beneficially owned following transactions reported on this form.